Projects per year
Abstract
Shared parameter joint models provide a framework under which a longitudinal response and a time-to-event can be modelled simultaneously. A common assumption in shared parameter joint models has been to assume the longitudinal response is normally distributed. In this paper we instead propose a joint model which incorporates a two-part “hurdle” model for the longitudinal response, motivated in part by longitudinal response data which is subject to a detection limit. The first part of the hurdle model estimates the probability that the longitudinal response is observed above the detection limit, whilst the second part of the hurdle model estimates the mean of the response conditional on having exceeded the detection limit. The time-to-event outcome is modelled using a parametric proportional hazards model, assuming a Weibull baseline hazard. We propose a novel association structure whereby the current hazard of the event is assumed to be associated with the current combined (expected) outcome from the two parts of the hurdle model. We estimate our joint model under a Bayesian framework and provide code for fitting the model using the Bayesian software Stan. We use our model to estimate the association between HIV RNA viral load, which is subject to a lower detection limit, and the hazard of stopping or modifying treatment in HIV patients initiating antiretroviral therapy.
Original language | English |
---|---|
Pages (from-to) | 3583-3594 |
Number of pages | 12 |
Journal | Statistics in Medicine |
Volume | 35 |
Issue number | 20 |
Early online date | 29 Mar 2016 |
DOIs | |
Publication status | Published - 10 Sept 2016 |
Keywords
- joint model
- shared parameter model
- hurdle model
- detection limit
- censoring
Fingerprint
Dive into the research topics of 'Joint longitudinal hurdle and time-to-event models: an application related to viral load and duration of the first treatment regimen in HIV patients initiating therapy'. Together they form a unique fingerprint.Projects
- 1 Finished
-
ART-CC: Prognosis of HIV-infected patients treated with ART
Sterne, J. A. C. (Principal Investigator), Ingle, S. M. (Researcher) & May, M. T. (Co-Principal Investigator)
1/02/12 → 1/02/15
Project: Research